BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dimethaid Research (DMX.TO) Waives Deadline For Deposit Of Proxies


10/19/2005 5:11:29 PM

TORONTO, Sept. 17 /PRNewswire-FirstCall/ -- To decrease confusion surrounding the solicitation of proxies by a dissident shareholder group, Dimethaid Research Inc. (TSX:DMX) has waived the 9:00 a.m., September 17, 2004 deadline for depositing proxies to be used at the Annual General Meeting. The company has taken this action to make sure all shareholders have an opportunity to exercise their voting rights. Proxies can be submitted any time before 9:00 a.m., EST, September 21, 2004. Shareholders should note that unsubmitted proxies will not count for either side.

Dimethaid urges all shareholders to vote "FOR" management's slate of directors, a recommendation endorsed by Fairvest Corporation, Canada's leading independent proxy advisory firm.

A copy of Dimethaid's management information circular and the accompanying "BLUE" proxy form have been mailed to shareholders and filed with the Canadian securities regulatory authorities at http://www.sedar.com/. Shareholders who have not received this package should immediately contact Kingsdale Shareholder Services, toll free, at 1-866-749-5464.

Shareholders who have voted for the dissidents can change their vote to support management by contacting Kingsdale.

About Dimethaid

Dimethaid Research Inc. is a publicly traded, Canadian, pharmaceutical company headquartered in Markham, Ontario, with manufacturing facilities in Varennes, Quebec and Wanzleben, Germany. The company develops and commercializes targeted therapeutic drugs designed to produce minimal side effects. Dimethaid's two technology platforms focus on transcellular drug delivery and immune system regulation. Products are aimed at expanding treatment options in rheumatology, dermatology, oncology, immunology, and the therapeutic management of chronic viral infections. For more information, please visit http://www.dimethaid.com/.

This release may contain forward-looking statements, subject to risks and uncertainties beyond management's control. Actual results could differ materially from those expressed here. Risk factors are discussed in the Company's annual information form filed with the securities commissions in each of the provinces of Canada. The Company undertakes no obligation to revise forward-looking statements in light of future events.

Dimethaid Research Inc.

CONTACT: Dimethaid Research Inc., Jodi Peake, Manager, IR & CorporateCommunications, Tel: (905) 415-1446 ext. 257; Kingsdale Shareholder Services,Toll-free: 1-866-749-5464, Fax: (416) 867-2271; Renny Ho, Investor RelationsOfficer, Tel: (905) 415-1446 ext. 251, Email: info@dimethaid.com;Archived images on this organization are available through CNW E-Pix athttp://www.newswire.ca/. Images are free to members of The Canadian Press;To request a free copy of this organization's annual report, please go tohttp://www.newswire.ca/ and click on reports@cnw.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES